Analysts think FBRX stock price could increase by 1639%
Sep 26, 2024, 11:26 AM
-29.11%
What does FBRX do
Forte Biosciences, a Dallas-based biopharmaceutical company, specializes in dermatology products and is advancing product candidate FB-102 for autoimmune diseases. The company went public on April 13, 2017, and holds a U.S. patent for skin treatment.
4 analysts think FBRX stock price will increase by 1638.64%. The current median analyst target is $114.75 compared to a current stock price of $6.60. The lowest analysts target is $75.75 and the highest analyst target is $157.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
